| abstract |
The invention relates to the compounds of the formula (I): (see formula (I)) wherein the substituents are as defined in the specification, in free form or in the form of a pharmaceutically acceptable salt, solvate, ester , N-oxide thereof; to processes for their preparation; to pharmaceutical products containing these compounds, in particular for use in one or more diseases mediated by protein tyrosine kinase. |